|
related topics |
{acquisition, growth, future} |
{cost, operation, labor} |
{product, liability, claim} |
{stock, price, share} |
{regulation, government, change} |
{operation, natural, condition} |
{personnel, key, retain} |
{cost, regulation, environmental} |
{stock, price, operating} |
{customer, product, revenue} |
{product, market, service} |
{capital, credit, financial} |
{gas, price, oil} |
{control, financial, internal} |
{provision, law, control} |
{property, intellectual, protect} |
|
Steady or declining market prices, and increased costs, could reduce profitability
Changes in demand for blood products could affect profitability
Declining blood donations could affect profitability
Competition may cause a loss of customers and an increase in costs and impact profitability
Operations depend on services of qualified professionals and competition for their services is strong
Industry regulations and standards could increase operating costs
Decrease in reimbursement rates may affect profitability
Targeted partner blood drives involve higher collection costs
Not-for-profit status gives advantages to competitors
Reliance on relatively few vendors for significant supplies and services could affect the Company s ability to operate
Potential adverse effect from changes in the healthcare industry, including consolidations, could affect access to customers
Future technological developments or alternative treatments could jeopardize business
Potential inability to meet future capital needs could affect plans to finance future expansion
Limited access to insurance could affect ability to defend against possible claims
Ability to attract, retain and motivate management and other skilled employees
Product safety and product liability could provide exposure to claims and litigation
Lease for a major production facility has expired and if the Company needs to vacate it may be unable to locate an alternative facility thereby disrupting business
Environmental risks could cause the Company to incur substantial costs to maintain compliance
Business interruption due to terrorism and increased security measures in response to terrorism
Business interruption due to hurricanes or earthquakes could adversely impact profitability
Evaluation and consideration of strategic alternatives, and other significant projects, may distract management from reacting appropriately to business challenges and lead to reduced profitability
Strategy to acquire companies may result in unsuitable acquisitions or failure to successfully integrate acquired companies, which could lead to reduced profitability
Articles of Incorporation and Rights Plan could delay or prevent an acquisition or sale of HemaCare
Quarterly revenue and operating results may fluctuate in future periods, and the Company may fail to meet investor expectations
Stocks traded on the OTC Bulletin Board are subject to greater market risks than those of exchange-traded and Nasdaq stocks since they are less liquid
Stock price could be volatile
Future sales of equity securities could dilute the Company s common stock
Evaluation of internal control and remediation of potential problems will be costly and time consuming and could expose weaknesses in financial reporting
Full 10-K form ▸
|
|
related documents |
801748--3/21/2006--HEMACARE_CORP_/CA/ |
801748--4/14/2008--HEMACARE_CORP_/CA/ |
801748--3/26/2009--HEMACARE_CORP_/CA/ |
898437--3/12/2008--ANIKA_THERAPEUTICS_INC |
898437--3/9/2009--ANIKA_THERAPEUTICS_INC |
1065087--3/17/2008--ALBANY_MOLECULAR_RESEARCH_INC |
1103017--4/15/2009--DENTAL_PATIENT_CARE_AMERICA_INC |
1020859--9/30/2009--UNITED_NATURAL_FOODS_INC |
812191--3/14/2007--REHABCARE_GROUP_INC |
1065087--3/15/2007--ALBANY_MOLECULAR_RESEARCH_INC |
1166003--3/27/2008--EXPRESS-1_EXPEDITED_SOLUTIONS_INC |
1036968--3/18/2009--VAXGEN_INC |
1166003--3/29/2007--EXPRESS-1_EXPEDITED_SOLUTIONS_INC |
95366--1/15/2008--SUNAIR_SERVICES_CORP |
922863--3/14/2008--QUALITY_DISTRIBUTION_INC |
922863--3/13/2009--QUALITY_DISTRIBUTION_INC |
1020859--9/27/2010--UNITED_NATURAL_FOODS_INC |
1046257--2/27/2007--CORN_PRODUCTS_INTERNATIONAL_INC |
1046257--3/9/2006--CORN_PRODUCTS_INTERNATIONAL_INC |
780127--1/5/2010--SYNOVIS_LIFE_TECHNOLOGIES__INC |
1046257--2/29/2008--CORN_PRODUCTS_INTERNATIONAL_INC |
1065087--3/16/2006--ALBANY_MOLECULAR_RESEARCH_INC |
893816--3/16/2007--INFOCROSSING_INC |
61986--3/1/2010--MANITOWOC_CO_INC |
862668--9/29/2008--ESCALON_MEDICAL_CORP |
893816--3/15/2006--INFOCROSSING_INC |
884064--3/16/2007--OPTION_CARE_INC/DE |
920527--5/20/2009--PSS_WORLD_MEDICAL_INC |
882873--9/17/2010--UROLOGIX_INC |
1324948--6/16/2006--RBC_Bearings_INC |
|